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Neonatal infections affect about 7 million neonates causing over 600 000 deaths every year. Estimating the
burden is challenging as there are multiple reporting criteria and deﬁnitions for serious bacterial infections in
neonates. Essential criteria for reporting serious neonatal bacterial infections have recently been published as
the STROBE-NI checklist and, in the context of maternal vaccination, deﬁnitions have been published by the
Brighton Collaboration Global Alignment of Immunization safety Assessment in pregnancy (GAIA) project.
Standardisation of reporting criteria is essential to allow data comparability. This an important step in provid-
ing a clearer picture of the burden of serious bacterial infections in neonates and a welcome progress for
guiding new investments in interventions.
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In the neonatal period over 600 000 deaths every year are directly
due to infections, with the highest burden in low and middle
income countries (LMICs).1 The burden of clinically deﬁned possible
serious bacterial infections in neonates is high. Meta-analyses of
studies from sub Saharan Africa, South Asia and Latin America
estimate that 6.9 million neonates need treatment for possible
serious bacterial infections each year:2 this is over 3 times the
yearly burden of new HIV infections in children under 15 years of
age.3 Neonatal infections and mortality are highest in the ﬁrst 24
hours after birth and are disproportionally more common in low
income countries, where most births occur at home. In these set-
tings capturing the burden of early infections and deaths
is logistically challenging, even as part of research studies, because
births and deaths are regularly not reported.
Global estimates that speciﬁcally reﬂect aetiology, antimicro-
bial resistance patterns and outcome have never been possible
due limited access to diagnosis and treatment in the highest
burden settings, as well as inconsistency of clinical diagnosis.
Few countries have adequate surveillance systems for neonatal
infection and the burden of impairment after neonatal infection
is also not well established.4
Deﬁnitions of serious bacterial infection in neonates vary and
there are no universally accepted standards. Underlying this are
the challenges of diagnosing serious bacterial infection, which
is usually based on simple clinical algorithms due to limited
laboratory facilities in LMICs. Even where available, blood cul-
tures are often negative due to small volume samples and fre-
quent contamination. Molecular methods using nucleic-acid
extraction are highly sensitive, but bring their own challenges of
interpretation and are mostly limited to research settings.
Tables 1, 2 and 3 illustrate the plethora of deﬁnitions and
reporting criteria used by current neonatal networks and epidemio-
logical units, mostly based in high income countries. Substantial
differences in deﬁnitions of serious bacterial infections make com-
parisons between studies difﬁcult, even when raw data are com-
pared, because different indicators are collected. Some deﬁnitions
and criteria are widely used to inform research studies, but are
often adapted to local circumstances rendering the resulting data
incomparable.
The variation in clinical deﬁnitions and research reporting criteria
for neonatal infections is partly due to the existence of a number
of types of surveillance networks, which have been designed for
different purposes. These include clinical networks monitoring all
aspects of neonatal care (e.g. International Neonatal Network,
iNEO), networks which focus on infections in (mostly adult) inten-
sive care settings and epidemiological networks such as those
coordinated by the US Centers for Disease Control (CDC) and the
European Medicine Agency (EMA), which supervises the develop-
ment and evaluation of new and existing drugs. There are also a
limited number of surveillance groups focusing speciﬁcally on
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Table 1. Comparison of deﬁnitions for culture proven blood stream infections
Current network
deﬁnitions
NEOKISS; European Centre for
Disease Control (ECDC)
European Medicine
Agency (EMA)
Centers for Disease
Control and
Prevention/National
healthcare safety
network (CDC-NHSN);
Canadian Neonatal
Network (CNN);
International
Nosocomial
Infection Control
Consortium (INICC)
Egyptian Neonatal
Network (EGNN)
Australian and
New Zealand
Neonatal
Network
(ANZNN)
Neonatal Data
Analysis Unit (NDAU)
Global Alignment of
Immunization safety
Assessment in
pregnancy (GAIA) -
Level 1 deﬁnition;
European Neonatal
Network (ENN);
Oxford Vermont
Neonatal Network
(OVN); Neonatal
Infection
Surveillance
Network (NEONIN)
Microbiological criteria:a 3 of the following:
Pathogen isolated
from blood culture or
CSF AND Pathogen not
related to infection in
other site
✓ ✓ ✓ ✓ ✓ ✓ ✓
OR
Positive CRP or
abnormal
haemogram
Recognized
pathogen identiﬁed
using a validated
method and from
a normally sterile
site
Number of additional
criteria:
AND at least two of: AND at least two of: At least one of: AND two or more
clinical signs of
sepsis (not
speciﬁed)
AND AND at least three of:
Patients receiving
antibiotics for at least
5 days (or <5 days if
transferred or died
before completion of
these 5 days)
✓ ✓
Clinical signs: Clinical picture
consistent with
neonatal infection
Temperature instability ✓ Fever or
hypothermia or
temperature
instability.
✓ ✓ ✓
Cardiovascular signs ✓ Tachycardia or new
or more frequent bradycardia.
✓ ✓ Bradycardia ✓ Hypotension
✓ Fall in urine
output
Continued149
Table 1. Continued
Current network
deﬁnitions
NEOKISS; European Centre for
Disease Control (ECDC)
European Medicine
Agency (EMA)
Centers for Disease
Control and
Prevention/National
healthcare safety
network (CDC-NHSN);
Canadian Neonatal
Network (CNN);
International
Nosocomial
Infection Control
Consortium (INICC)
Egyptian Neonatal
Network (EGNN)
Australian and
New Zealand
Neonatal
Network
(ANZNN)
Neonatal Data
Analysis Unit (NDAU)
Global Alignment of
Immunization safety
Assessment in
pregnancy (GAIA) -
Level 1 deﬁnition;
European Neonatal
Network (ENN);
Oxford Vermont
Neonatal Network
(OVN); Neonatal
Infection
Surveillance
Network (NEONIN)
Respiratory distress ✓ Increased oxygen requirement
(intubation)
✓ Tachypnoea ✓ Increased oxygen
requirement or respiratory
support
Apnoea ✓ New or more frequent apneas. ✓ ✓ ✓ New or more frequent
apnoeas or bradycardias
Signs of poor perfusion ✓ CRT>2 s ✓ Sclerema ✓ CRT>2 s or impaired
peripheral perfusion✓ Skin color (only when
recapillarization time is not used)
✓ Mottled skin
Feeding intolerance ✓ ✓ Ileus
Central nervous
system signs
✓ Unstable condition, apathy ✓ Lethargy,
irritability and
hypotonia
✓ Lethargy
Glucose intolerance ✓ New hyperglycema. ✓ ✓ Glucose intolerance
Metabolic acidosis (BE
≤10 mEq/L)
✓ Unexplained metabolic acidosis ✓ or lactate>2
mMol/L
✓ Unexplained metabolic
acidosis
Laboratory criteria: AND two of:
Abnormal platelet
count.
Plt<1×1014
Abnormal WCC I/T>0.2
Abnormal CRP or
interleukin
✓ Increased CRP, interleukin
(not included in ECDC
deﬁnition)
✓ CRP>15 mg/L
or procalcitonin
≥2 ng/ml
BE: base excess; CRP: C reactive protein; CRT: capillary reﬁll time; CSF: cerebrospinal ﬂuid; I/T: immature to total neutrophil ratio; mEq/L: milliequivalents per litre; Plt: platelet; WCC: white cell count.
Infection networks: INICC: international nosocomial infection control consortium (international healthcare associated infection database and infection control packages): NEOKISS: German neonatal infections net-
work including only very low birth weight babies (birth weight<1500g) – developed from adult and paedaitric intensive care and focusing on health care associated infections; NEONIN; neonatal infection surveillance
network (UK, Australia, Greece and Estonia - neonatal infection database collecting data on all neonatal infections in all infants admitted to neonatal units).
Neonatal networks (including neonatal infection deﬁnitions): ANZNN: Australian and New Zealand neonatal network; CNN: Canadian neonatal network (national neonatal network); EGNN: Egyptian neonatal network;
ENN: European neonatal network (neonatal network); NDAU: neonatal data analysis unit (UK based national database); OVN: Oxford Vermont neonatal network.
Primarily epidemiological and trial units: (E)CDC: (European) centre for disease control (epidemiological purposes); EMA: European Medicine Agency; GAIA: global alignment of immunization safety assessment in preg-
nancy; NHSN: national healthcare safety network (part of CDC tracking health care associated infections).
a EMA and ANZNN also include positive PCR/antigen testing.
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Table 2. Comparison of deﬁnitions for blood stream infections when common commensals are isolated
Bloodstream infection
deﬁnition criteria
NEOKISS; European Medicine
Agency (EMA); European Centre for
Disease Control (ECDC)
Centers for Disease Control
and Prevention/National
healthcare safety network
(CDC-NHSN); Canadian
Neonatal Network (CNN)a
International
Nosocomial Infection
Control Consortium
(INICC)
European neonatal
network (ENN);
Oxford Vermont
neonatal network
(OVN)
Neonatal Data Analysis
Unit (NDAU)
Australian and New
Zealand Neonatal
Network (ANZNN)
Global Alignment of
Immunization safety
Assessment in
pregnancy (GAIA) –
Level 1 deﬁnition
Microbiological criteria:
At least 2 or more
positive BC with the
same organism
drawn on separate
occasions (within 2
days of each other)
CoNS isolated in blood culture as
sole pathogen
✓ ✓ CoNS recovered from
a blood culture obtained
from either a central
line or peripheral blood
sample, and/or is recovered
from CSF obtained by lumbar
puncture, ventricular tap or
ventricular drain
Mixed growth or skin
commensal
✓ ✓
Number of additional
criteria:
AND at least two of: AND at least one of: AND at least three of: AND
Patient receiving
antibiotics for at least
5 days (or <5 days if
transferred or died
before completion of
these 5 days)
✓ ✓
Clinical signs: AND at least 1 of: AND clinically septic AND at least 1 of:
Temperature
instability
✓ Fever or hypothermia
or temperature
instability
✓ Fever,
hypothermia
✓ Fever ✓ Temperature
instability
✓ Temperature instability ✓ Temperature
≥37.5°C
or <35.5°C
Cardiovascular signs ✓ Tachycardia or new
or more frequent
bradycardia
✓ Bradycardia ✓ Hypotension ✓ Hemodynamic
instability
✓ Hypotension ✓ Tachycardia or new
or more frequent
episodes of
bradycardia
Signs of poor
perfusion
✓ CRT>2 s or skin color
(only when
recapillarization time
is not used)
✓ Chills ✓ Impaired peripheral
perfusion (CRT>3 s,
pallor/mottling/ core
peripheral temperature
gap >2°C.
✓ Pallor or poor
perfusion or
hypotension
Fall in urine output
Apnoeas ✓ New or more
frequent
✓ ✓ OR worsening
respiratory
distress
✓ Clinically relevant OR
bradycardia episodes
✓ Increased oxygen
requirement or
increased
requirement for
ventilatory support
Continued
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Table 2. Continued
Bloodstream infection
deﬁnition criteria
NEOKISS; European Medicine
Agency (EMA); European Centre for
Disease Control (ECDC)
Centers for Disease Control
and Prevention/National
healthcare safety network
(CDC-NHSN); Canadian
Neonatal Network (CNN)a
International
Nosocomial Infection
Control Consortium
(INICC)
European neonatal
network (ENN);
Oxford Vermont
neonatal network
(OVN)
Neonatal Data Analysis
Unit (NDAU)
Australian and New
Zealand Neonatal
Network (ANZNN)
Global Alignment of
Immunization safety
Assessment in
pregnancy (GAIA) –
Level 1 deﬁnition
Feeding intolerance ✓ ✓ OR Ileus ✓ Difﬁculty in feeding
or abdominal
distention.
Metabolic acidosis (BE
≤10 mEq/L)
✓ ✓ ✓
Glucose intolerance ✓ Hyperglycaemia AND ✓
Other signs of
bloodstream
infection
✓ Increased oxygen,
requirement
(intubation)
Clinical signs and laboratory
results are not related to an
infection in another site
Tachypnea or clinically
relevant increase in oxygen
requirement or ventilator
support
Central nervous
system signs
✓ Unstable condition,
apathy
Lethargy, irritability or poor
handling
✓ Lethargy or moving
only when
stimulated or
hypotonia or
irritability
Laboratory criteria: AND at least one of:
Abnormal CRP CRP>2.0 mg/dl other interleukin ✓ Increased number
of inﬂammatory
markers (CRP,
procalcitonin)
Abnormal WCC I/T ratio>0.2 (immature
granulocytes/total granulocytes)
OR leukocytopaenia (without
erythroblasts)
✓ ✓ OR I/T ratio > 0.2.
Abnormal platelet
count
Thromocytopaenia ✓ Thromocytopaenia ✓
BC: blood cultures; BE: base excess; CoNS: coagulase negative Staphylococci; CSF: cerebrospinal ﬂuid; CRP: C reactive protein; CRT: capillary reﬁll time; I/T: immature to total neutrophil ratio; mEq/L: milliequivalents per litre; WCC: white
cell count.
Infection networks: INICC: international nosocomial infection control consortium (international healthcare associated infection database and infection control packages); NEOKISS: German neonatal infections network including only
very low birth weight babies (birth weight<1500g) – developed from adult and paedaitric intensive care and focusing on health care associated infections.
Neonatal networks (including neonatal infection deﬁnitions): ANZNN: Australian and New Zealand neonatal network; CNN: Canadian neonatal network (national neonatal network); ENN: European neonatal network; NDAU: neonatal
data analysis unit (UK based national database); OVN: Oxford Vermont neonatal network.
Primarily epidemiological and trial units: (E)CDC: (European) centre for disease control (epidemiological purposes); EMA: European medicine agency (providing deﬁnitions used in clinical trials); GAIA: global alignment of immunization
safety assessment in pregnancy; NHSN: national healthcare safety network (part of CDC tracking health care associated infections).
a CNN has several deﬁnition criteria, one is listed in the table, the others are as follows: 1. Fever, chills or hypotension (or fever, hypothermia, apnoea or bradycardia) and common skin contaminant isolated from a blood culture in a
patient with intravascular access device AND the physician institutes appropriate antimicrobial therapy for at least 5 days; 2. The three clinical signs above and common skin contaminant isolated from patient’s blood culture and
physician institutes appropriate antimicrobial therapy for at least 5 days; 3. One of the three clinical signs above and positive antigen test on blood and organism is not related to infection in another site.
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Table 3. Comparison of deﬁnitions for culture negative blood stream infections (possible serious bacterial infection)
Deﬁnition for culture
negative blood stream
infection
NEOKISS; European
Centre for Disease Control
(ECDC)
European Medicine Agency (EMA) Centers for Disease
Control and Prevention/
National Healthcare
Safety Network (CDC-
NHSN); Canadian
Neonatal Network (CNN)
International
Nosocomial
Infection Control
Consortium
(INICC)
Egyptian Neonatal
Network (EGNN)
Young Infant Clinical
Study Group – WHO
(YICSG-WHO); Global
Alignment of
Immunization safety
Assessment in
pregnancy (GAIA)a
Level 3 deﬁnition
Global Alignment of
Immunization safety
Assessment in
pregnancy (GAIA)
Level 2 deﬁnition
All of the following: All of the following: In presence of a
central line:
Three of the following: GAIA any two of the
following; YICSG-WHO
at least one of the
following:
Antimicrobial therapy for
bloodstream infection
for at least 5 days
✓ ✓ ✓ ✓
Lack of positive
microbiology data or no
organism detected
✓ ✓ ✓ ✓ ✓ Positive CRP or
abnormal
haemogram
✓
No apparent infection at
another site
✓ ✓ ✓ ✓ ✓ Risk factors for
sepsis
(chorioamnionitis,
prematurity)
Number of necessary
criteria
AND at least two of: At least two clinical + two
laboratory signs:
AND at least one of: AND at least one
of:
Two clinical signs of
sepsis (not speciﬁed):
Three or more of:
Clinical signs:
Temperature
instability (fever or
hypothermia)
✓ ✓ ✓ ✓ ✓ Temperature
≥37.5°C or
<35.5°C
✓ Temperature
≥37.5°C or
<35.5°C
Signs of poor
perfusion
✓ CRT time>2s OR
skin color (only
when CRT is not
used)
✓ Hypotension
oliguria
✓ Pallor or poor
perfusion or
hypotension
Apnoea ✓ New or more
frequent
✓ ✓ ✓
Signs of respiratory
distress
✓ Increased O2
requirement
(intubation)
✓ Tachypnoea (mean respiratory
rate (RR)>2 SD above normal
for age) or increased oxygen
requirements or requirement
for ventilation support
✓ RR≥60. ✓ Increased oxygen
requirement or
increased
requirement for
ventilatory support
Severe chest
indrawing.
Cyanosis (GAIA
only)
Poor feeding ✓ Feeding intolerance, poor
sucking abdominal distention
✓ History of
difﬁculty feeding
✓ Difﬁculty in
feeding or
abdominal
distention
Continued
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Table 3. Continued
Deﬁnition for culture
negative blood stream
infection
NEOKISS; European
Centre for Disease Control
(ECDC)
European Medicine Agency (EMA) Centers for Disease
Control and Prevention/
National Healthcare
Safety Network (CDC-
NHSN); Canadian
Neonatal Network (CNN)
International
Nosocomial
Infection Control
Consortium
(INICC)
Egyptian Neonatal
Network (EGNN)
Young Infant Clinical
Study Group – WHO
(YICSG-WHO); Global
Alignment of
Immunization safety
Assessment in
pregnancy (GAIA)a
Level 3 deﬁnition
Global Alignment of
Immunization safety
Assessment in
pregnancy (GAIA)
Level 2 deﬁnition
Central nervous
system signs
✓ Unstable condition,
apathy
✓ Irritability, lethargy and
hypotonia
✓ Movement only
when
stimulated.
✓ Lethargy or
moving only when
stimulated or
hypotonia or
irritability
History of
convulsions
Cardiovascular
instability
✓ Tachycardia (>200/
min) or new/more
frequent
bradycardia
(<80/min)
✓ Bradycardia or tachycardia and/
or unexplained persistent
depression over a 0.5 h time
period) or rhythm instability
✓ Bradycardia ✓ Tachycardia or
new or more
frequent episodes
of bradycardia
Other signs of
infections
Petechial rash, sclerema
Glucose intolerance ✓ Hyperglycaemia ✓ Hyperglycaemia detected at
least 2 times or hypoglycaemia
Unexplained
metabolic acidosis
(BE≤10 mEq/l)
✓ ✓ OR increased serum lactate ✓
Laboratory parameters:
Abnormal CRP ✓ Laboratory evidence
(CRP, interleukin)
✓ Increased CRP or procalcitonin ✓ Increased
number of
inﬂammatory
markers (CRP,
procalcitonin)
Abnormal WCC ✓ Leucopoenia or leukocytosis or
>2×1013 cells/l
✓ OR I/T ratio>0.2
Immature to total neutrophil
ratio (I/T)>0.2
Abnormal platelet
count
✓ Thrombocytopoenia ✓
BE: base excess; CRP: C reactive protein; CRT: capillary reﬁll time; I/T: immature to total neutrophil ratio; mEq/L: milliequivalents per litre; RR: respiratory rate; WCC: white cell count.
Infection networks: INICC: international nosocomial infection control consortium (international healthcare associated infection database and infection control packages); NEOKISS: German neonatal infections net-
work including only very low birth weight babies (birth weight<1500g) – developed from adult and paedaitric intensive care and focusing on health care associated infections.
Neonatal networks (including neonatal infection deﬁnitions): CNN: Canadian neonatal network (national neonatal network); EGNN: Egyptian neonatal network; YICSG-WHO: young infant clinical study group – WHO.
Primarily epidemiological and trial units: (E)CDC: (European) centre for disease control (epidemiological purposes); EMA: European medicine agency (providing deﬁnitions used in clinical trials); GAIA: global alignment
of immunization safety assessment in pregnancy; NHSN: national healthcare safety network (part of CDC tracking health care associated infections).
a GAIA: global alignment of immunization safety assessment in pregnancy − 3 different levels of deﬁnitions are provided depending on the data available. Level 3 deﬁnition (not meeting level 1 or 2 deﬁnition of evidence
AND two or more of the following criteria): Temperature ≥37.5°C or <35.5°C; tachypnea or severe chest indrawing or grunting or cyanosis; change in level of activity; history of feeding difﬁculty; history of convulsions.
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neonatal infection (e.g. neonIN – the UK neonatal infection sur-
veillance network).5 Such networks play a particularly important
role in monitoring healthcare associated infections and are not
necessarily restricted to high income countries. For example, the
International Nosocomial Network Infection Control (INNIC)
database is a global initiative that aims to monitor and reduce
the rate of healthcare associated infections, particularly in
LMICs, and includes neonates.6
Deﬁnitions used for hospitalized neonates, especially in high
income countries, have limited value for early onset infection in
the community or in lower level health care settings with the
highest burden of disease. Simpler clinical deﬁnitions of serious
bacterial infections such as the WHO young infant deﬁnition,
are available and are essential for clinical decision making in
low-resource settings. These have been used in some of the few
available population-based studies. However, with wide varia-
tions in reporting between studies and different adaptations of
the original deﬁnitions, it remains extremely challenging to rec-
oncile differences in data for large-scale analysis of burden,
aetiology and outcomes after interventions.
Addressing these issues, two recent collaborative projects
have made important steps towards improved reporting of neo-
natal infection data. The Strengthening Publications Reporting
Infections in Newborns Globally (SPRING) group was formed in
2015 with the intention of reducing some of the heterogeneity
by reaching a consensus on essential reporting criteria for neo-
natal infection data. The group is an expert panel of clinicians,
academics, researchers, epidemiologists, funders and statisti-
cians. Following a systematic literature review, they prepared
and disseminated a survey of possible reporting criteria to a
large group of experts from 37 countries representing all 5 con-
tinents. The reporting criteria were then discussed in a consen-
sus meeting and 28 ﬁnal items were included in the STROBE-NI
(Strengthening the Reporting of Observational Studies in Epidemi-
ology for Neonatal Infection) checklist, published in September
2016.7 It is hoped that the STROBE-NI criteria will not only
improve reporting, but also indirectly shape research and study
design. Deﬁnitions for neonatal bloodstream infections, meningi-
tis and respiratory infections have been produced by the Brighton
Collaboration Global Alignment of Immunization safety Assess-
ment in pregnancy (GAIA) project, aiming to deﬁne neonatal
infection in the context of maternal vaccine studies.8
As improving newborn survival gains recognition as a key glo-
bal health priority, these new international guidelines will be
essential in supporting quality research in serious bacterial infec-
tions and possible serious bacterial infections, estimates of the
burden of disease and for the evaluation of interventions aimed
at pregnant women, neonates and infants.
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